eniwru

Notice: Google Translator translates the texts only for guidance.

CBD applications

CBD applications

Medical research and information

Summary

  • Seventy-two percent of participants with fibromyalgia substituted CBD for pain medications.
  • Participants often substituted CBD for opioids (53.3%) and benzodiazepines (23.1%).
  • Seventy to 94% of reported substitutions resulted in stopped or reduced use of medications.
  • Participants substituted for harm reduction reasons (eg, fewer side effects).
People report substituting cannabis for pain medications, but whether cannabidiol (CBD) is used similarly remains unknown. CBD products can be CBD alone (isolate), hemp extract (containing <0.3% Δ-9-tetrahydrocannabinol [THC], other cannabinoids, and terpenes), or CBD-cannabis (containing >0.3% THC). In a secondary analysis from a cross-sectional survey, we examined substitution patterns among n = 878 individuals with fibromyalgia who currently used CBD. We sub-grouped participants by most commonly used CBD product (CBD isolate, hemp, CBD-cannabis, no preference) and whether they substituted CBD for medications. We investigated rationale for substituting, substitution-driven medication changes, CBD use patterns, and changes in pain-related symptoms (eg, sleep, anxiety). The study population was 93.6% female and 91.5% Caucasian, with an average age of 55.5 years. The majority (n = 632, 72.0%) reported substituting CBD products for medications, most commonly NSAIDs (59.0%), opioids (53.3%), gabapentanoids (35.0%), and benzodiazepines (23.1%). Most substituting participants reported decreasing or stopping use of these pain medications. The most common reasons for substitution were fewer side effects and better symptom management. Age, hemp products, past-year use of marijuana, and higher somatic burden were all associated with substituting (P’s ≤ .05). Those who substituted reported larger improvements in health and pain than those who did not. Participants using CBD-cannabis reported significantly more substitutions than any other group (P’s ≤ .001) and larger improvements in health, pain, memory, and sleep than other subgroups. This widespread naturalistic substitution for pain medications suggests the need for more rigorous study designs to examine this effect.
 
This article shows that people with fibromyalgia are deliberately substituting CBD products for conventional pain medications despite the dearth of evidence suggesting CBD products may be helpful for fibromyalgia. CBD's medication-sparing and therapeutic potential should be examined in more rigorous study designs.

Our services

Our company UNIMED SGS Ltd is the distributor for Dragonfly Biosciences Limited, United Kingdom. We offer high-quality CBD bulk, white label and wholesale solutions.

Wholesale options

  • White labelling
  • Bulk Extract/Formulation on request
  • Bespoke formulation requests also available
  • Flavours & additional ingredients available on request
  • R&D Fee for unique formulation, three amendments with samples

Contact us

Disclaimer

©2021 UNIMED SGS Ltd. All rights reserved. All trade marks on this website are the property of their respective owners.

Sorry, this website uses features that your browser doesn’t support. Upgrade to a newer version of Firefox, Chrome, Safari, or Edge and you’ll be all set.